Boron Neutron Capture Therapy in Treating Patients With Melanoma
Melanoma (Skin)

About this trial
This is an interventional treatment trial for Melanoma (Skin) focused on measuring recurrent melanoma, stage 0 melanoma, stage I melanoma, stage II melanoma, stage III melanoma, stage IV melanoma
Eligibility Criteria
DISEASE CHARACTERISTICS: Histologically confirmed melanoma Evaluable disease Lesion(s) to be irradiated must be located in 1 of the following areas: On an extremity On the head or neck (including the scalp) In the subdermal lymphatics (excluding the proximal axilla) Area to be irradiated must not exceed a maximum dimension of 10 cm Maximum tumor depth from the surface of the skin cannot exceed 6 cm PATIENT CHARACTERISTICS: Age 18 and over Performance status ECOG 0-1 Life expectancy More than 6 months Hematopoietic Not specified Hepatic Not specified Renal Creatinine normal Cardiovascular No history of severe cardiac disease No uncontrolled arrhythmias or conduction defects No unstable or newly diagnosed angina pectoris No recent coronary artery disease No congestive heart failure Other Not pregnant Negative pregnancy test No history of phenylketonuria Must have sufficient mental competence PRIOR CONCURRENT THERAPY: Biologic therapy Not specified Chemotherapy Not specified Endocrine therapy Not specified Radiotherapy No prior radiotherapy to study sites Surgery Not specified
Sites / Locations
- Beth Israel Deaconess Medical Center
- Massachusetts Institute of Technology